ImportRefusal LogoImportRefusal

Dabur India

⚠️ Moderate Risk

FEI: 3004326849 • District Solan, Himachal Pradesh • INDIA

FEI

FEI Number

3004326849

📍

Location

District Solan, Himachal Pradesh

🇮🇳

Country

INDIA
🏢

Address

220-221, Industrial Area, Baddi, District Solan, Himachal Pradesh, India

Moderate Risk

FDA Import Risk Assessment

39.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
7
Unique Violations
11/3/2021
Latest Refusal
7/29/2004
Earliest Refusal

Score Breakdown

Violation Severity
67.5×40%
Refusal Volume
37.0×30%
Recency
2.0×20%
Frequency
5.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4882×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

3311×

DR QUALITC

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the drug appears to be represented as not being recognized in an official compendium and appears its strength differs from or its quality or purity falls below, that which it purports or is represented to possess.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
11/3/2021
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of West Coast Imports (DWCI)
8/14/2012
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Chicago District Office (CHI-DO)
12/20/2007
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
331DR QUALITC
New Orleans District Office (NOL-DO)
1/25/2007
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
8/12/2005
66VBR99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
5/19/2005
66VBR99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
9/18/2004
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
9/18/2004
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
7/29/2004
63HBL99CATHARTIC N.E.C.
118NOT LISTED
472NO ENGLISH
75UNAPPROVED
San Francisco District Office (SAN-DO)

Frequently Asked Questions

What is Dabur India's FDA import refusal history?

Dabur India (FEI: 3004326849) has 9 FDA import refusal record(s) in our database, spanning from 7/29/2004 to 11/3/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dabur India's FEI number is 3004326849.

What types of violations has Dabur India received?

Dabur India has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Dabur India come from?

All FDA import refusal data for Dabur India is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.